Confidential FDA Mefloquine Report sent to CDC

Dr. Remington Nevin filed this request with the Food and Drug Administration of the United States of America .
Tracking #




From: Remington Nevin

To Whom It May Concern:

This is a request under the Freedom of Information Act. I hereby request the following records:

A copy of the document described as a "confidential mefloquine report" sent as an email attachment by FDA to Dr. Paul Arguin ( at the Centers for Disease Control (CDC) on or about August 8, 2013 (see responsive documents at In processing this request, please be advised the report may have a filename similar to "rev_cases of disabling neuropsych events mefloquine 5 24 2013 eos ja (2)addendum_Redated.pdf", and may have been sent by Dr. Sumathi Nambiar ( at FDA CDER.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that fees cannot be waived, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.


Dr. Remington Nevin

From: Food and Drug Administration

An acknowledgement letter, stating the request is being processed.

From: Food and Drug Administration

A copy of documents responsive to the request.

From: Food and Drug Administration

A cover letter granting the request and outlining any exempted materials, if any.

From: Nicolas, Diderot

Hello Mr. Nevin,

I am writing to inform you that the responsive records associated with the subject request were mailed to your P.O. Box 55819 address October 21, 2015. Therefore, you should receive them shortly. Thanks.